Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 4, 2017Journal of Medicinal Chemistry

Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier

View Full Paper
Ask AI
Bookmark
Share

Authors

IMIlaria MonacoAzienda Universitaria Ospedaliera Consorziale - Policlinico BariSCSimona CamoraniNational Academies of Sciences, Engineering, and MedicineDCDavid ColecchiaDecImmune Therapeutics (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Monaco et al. (2017) studied this question.

synapsesocial.com/papers/6a08c9c28bd2868868ba059dhttps://doi.org/10.1021/acs.jmedchem.7b00527
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier2011 · 4,803 citations
  2. 2Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism1999 · 1,373 citations
  3. 3Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation2015 · 261 citations
  4. 4Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers2009 · 68 citations
  5. 5The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses2007 · 725 citations